Longitudinal Idiopathic Pulmonary Fibrosis Registry To Identify Biomarkers Of Disease Save

Date Added
January 12th, 2016
PRO Number
Pro00050522
Researcher
Lynn Schnapp
Keywords
Lung, Pulmonary
Summary

This study will measure biomarkers in order to monitor and predict health states of disease progression in subjects with Idiopathic Pulmonary Fibrosis (IPF) over 5 years.

The study will consist of a naive (drug free) cohort if subjects have not already been on pirfenidone or nintedanib. Once in the open-label treatment group, subjects will be on either pirfenidone or nintedanib. Subjects will be asked to have blood drawn at their standard of care visits with the option of volunteering for two additional sub-studies.

Institution
MUSC
Recruitment Contact
Farah Stokes
843-792-0373
flaitz@musc.edu

Change_preferences

-- OR --

Create_login